COVID-19

Outbreaks of infectious diseases have been recorded throughout history. Currently, SARS-CoV-2, a contagious virus that causes the disease called COVID-19, is impacting individuals worldwide. Many countries have set their sight on an effective vaccination program to end their infectious disease outbreaks. The term “herd immunity” has been mentioned in association with ending the COVID-19 outbreaks.
0 Comments
Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. A scoring system based on 10 parameters in a complete blood count (CBC) with differential within 3 days of hospital presentation predict those with COVID-19 who are most likely to progress to critical illness, new evidence shows. Advantages include prognosis based on a common
0 Comments
Smell loss – called anosmia – is a common symptom of COVID-19. For the past nine months, the two of us – a sensory scientist and an infectious disease epidemiologist – have applied our respective expertise to develop smell-based screening and testing programs as part of a response to the SARS-CoV-2 pandemic. In early October,
0 Comments
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Dec. 23, 2020– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order. “I want to thank Health
0 Comments
Now that the first COVID-19 vaccines are being rolled out, Operation Warp Speed, the FDA, and the CDC have recommended that governors proceed first with vaccinating two groups: healthcare workers and residents in nursing homes. But what about after that? Planning has started in all the states and territories regarding who will get the vaccine
0 Comments
National Institutes of Health Director Dr. Francis Collins told CNBC that “it was very likely” that the U.S. government is close to a deal with Pfizer for up to an additional 100 million Covid vaccine doses.  “It is good news it sounds like it’s very likely,” said Collins. “We’ll have 400 million doses between Pfizer
0 Comments
The worldwide impact of influenza on mortality remains one of the most adverse of any infectious disease. In the United States alone, the Centers for Disease Control and Prevention estimate that flu has resulted in between 9 million – 45 million illnesses, between 140,000 – 810,000 hospitalizations, and between 12,000 – 61,000 deaths annually since
0 Comments
Drug used for type 2 diabetes – metformin – may improve COVID-19 outcomes. The SARS-CoV-2 pandemic has spread across the globe with unprecedented speed, affecting every corner of the planet. One of the few positives to emerge from this is the opportunities it has provided for analysing real-world evidence. The pandemic has generated mountains of
0 Comments
At-home tests are convenient; ask anyone who has used an over-the-counter pregnancy test. Until now, all Covid-19 testing has been done by a medical practitioner. But, the days of queuing in car lines or at urgent care centers may be over. The FDA has granted Emergency Use Authorization for an at-home testing kit. The test
0 Comments
Early on in the ongoing coronavirus disease 2019 (COVID-19) pandemic, the antibiotic azithromycin was regarded as being a potentially highly effective drug against the virus that causes it, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Hundreds of thousands of doses have been dispensed on this basis to treat these patients. Evidence in support of this
0 Comments
As the coronavirus disease (COVID-19) threatens the globe infecting over 43.8 million people, the development of a vaccine against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is of paramount importance. Apart from the dissemination of the vaccine, its acceptance among the public is also crucial. Obtaining a high uptake of the vaccine will be
0 Comments
Print this page PLYMOUTH MEETING, Pa., Sept. 28, 2020 /PRNewswire/ — INOVIO (NASDAQ:INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. Food and Drug Administration (FDA) has notified the company it has additional questions about the company’s
0 Comments